Moneycontrol Be a Pro
Get App
Last Updated : Aug 14, 2015 12:09 PM IST | Source: Moneycontrol.com

Cipla Q1 profit seen up 47% on higher other income, revenue

In Q1FY15, other income declined 41 percent to Rs 40.39 crore, which impacted bottomline as well. The pharma company will announce its earnings on August 14.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug maker Cipla is expected to report a whopping 47 percent growth in first quarter profit at Rs 433.4 crore compared to Rs 294.6 crore in the year-ago period, according to average of estimates of analysts polled by CNBC-TV18. Profit growth may be led by other income, overall performance in topline and EBITDA.


In Q1FY15, other income declined 41 percent to Rs 40.39 crore, which impacted bottomline as well. The pharma company will announce its earnings on August 14.


Revenue is likely to increase 24.2 percent to Rs 3,378 crore in June quarter compared to Rs 2,720 crore in same quarter last fiscal, driven by export formulations.

Close

Analysts expect export formulations (which contribute 50 percent to sales) growth at 25-30 percent led by supply of Nexium generic capsules to Teva while domestic business may be steady in Q1.


Operating profit (earnings before interest, depreciation and amortisation) may surge 32 percent year-on-year to Rs 714 crore and margin may expand 117 basis points to 21.1 percent in the quarter gone by.


Cipla, after its Q4FY15 earnings, said it expects 15 percent revenue growth and 150 basis points margin expansion.




The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Aug 14, 2015 09:36 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant
Make every wish come true
10% CashBack on Apparel
10% CashBack on Electronics
Swipe & Win iPhone 11 every hour